ArticleVaccines2025

A Phase III Clinical Trial of Immunogenicity and Safety of Meningococcal A and C Polysaccharide Conjugate Vaccine in Infants Aged 3-5 Months.

Liwei Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.